Redefining Ex-US Success in an MFN World
In an MFN-driven pricing environment, ex-US success is no longer defined by rapid launch and broad footprint, but by deliberate, portfolio-level decisions that protect global value. Ex-US strategy is shifting from local optimisation to active stewardship of global pricing and policy risk.
For many years, success in ex-US markets was relatively well defined. Launch quickly, achieve broad geographic coverage, secure reimbursement at the best achievable price, and maintain consistency across markets. Although execution was complex, the overall logic was clear, with pricing flowing mainly in one direction and limited upstream impact on ex-US markets. That logic is now being challenged.
MFN-style US pricing policies, alongside increasing reliance on international benchmarks and net price signals, mean that ex-US markets are no longer downstream executors of global strategy. They are increasingly inputs into global pricing risk. Decisions taken in one market can now influence outcomes elsewhere, including in the US, in ways that were not previously anticipated.
The fundamental shift: Ex-US markets are no longer downstream executors of global strategy, they are inputs into global pricing risk.
Redefining Success Metrics
In this environment, traditional measures of ex-US success begin to look incomplete. Rapid launch and wide footprint may still matter, but they are no longer neutral objectives. Instead, ex-US strategy is increasingly being judged on its ability to protect global value.
Traditional Metrics
- Rapid launch
- Broad footprint
- Best local price
- Local optimisation
MFN World Metrics
- Strategic timing
- Selective presence
- Global value protection
- Portfolio coordination
Launch Sequencing as Strategic Control
One visible consequence is the changing role of launch sequencing. What was once a largely tactical exercise has become a strategic control lever. Timing, price visibility, and market choice now carry implications beyond local access, shaping global exposure and optionality.
As a result, delayed or selective launch, and in some cases, deliberate non-launch – is emerging as a rational strategic choice rather than a failure of execution.
Reframing Market Presence
This also changes how market presence is defined. Being present everywhere is no longer synonymous with success. Instead, the focus is shifting towards being present where presence does not create disproportionate global risk.
This reframing is uncomfortable, particularly for teams accustomed to being measured on access expansion, but it reflects the realities of a more interconnected pricing environment.
Tariffs and Manufacturing
Alongside pricing, tariffs are adding another dimension to value protection. Decisions about where products are manufactured, supplied, and prioritised are increasingly intertwined with pricing strategy, reinforcing the need for deliberate geographic focus rather than default global rollout.
The Role of Non-Referenced Markets
At the same time, non-referenced or weakly referenced markets are taking on greater strategic relevance. Markets such as China, historically viewed through a volume or late-launch lens, may offer revenue opportunities without immediately feeding into IRP or MFN mechanisms.
This does not remove complexity, but it does broaden the strategic toolkit available to global teams.
Strategic Non-Referenced Markets
Major pharmaceutical markets outside the GLOBE/GUARD 19-country reference basket. Click markers for details.
Click a marker to view market details
Strategic Implications
- Launch sequencing is now a strategic control lever, not a tactical exercise
- Market selection requires evaluating global risk exposure, not just local opportunity
- Non-referenced markets may offer revenue without MFN/IRP implications
- Portfolio-level decisions require clearer global direction and stronger governance
The Bottom Line
These shifts point to a redefinition of ex-US success. It is no longer about local optimisation alone, but about coordinated stewardship of global value. That requires clearer global direction, stronger decision-making structures, and portfolio-level choices that are explicit about the trade-offs involved.
In an MFN world, ex-US strategy is not diminishing in importance. It is becoming central.

